Synthetic access to three neutral glycosphingolipids from the parasite Schistosoma mansoni adult worm has been achieved. These structures differ significantly from those of other parasites and exhibit a unique structural motif termed "schisto-core" consisting of GalNAcb b1→4Glcb b1→sequence. We have synthesized glycosphin- 
Investigation of the functional roles of mammalian carbohydrates in biological processes have been an area of intense study in recent years. 1) In contrast, much less time has been devoted to structures of glycosphingolipids (GSLs) from invertebrates that differ significantly from mammalian glycans. Due to these differences in the glycan structure we have been interested in the relationships between the structure and biological activity of GSLs from invertebrate species and have synthesized oligosaccharides found in various Protostomia phyla. [2] [3] [4] [5] [6] [7] [8] [9] In the course of our studies, we paid attention to the presence of unique GSLs found in the parasite, Schistosoma mansoni. 10) Makaaru et al. identified a novel glycan core structure termed "schisto-core" in the GSLs isolated from S. mansoni adult worm and they can be extended to other unique glycan sequences ( Fig. 1: A-F) . 11) Moreover, the parasite egg and the cercariae are a rich source of highly antigenic, multifucosylated GSLs. 10, 12, 13) Studies on the glycobiology of parasitic helminthes can contribute to a better understanding of glycolipid-mediated host-parasite interactions including species specific-and organ-specific infections but also will provide useful information how changes in the glycan structure relate to different stages in the parasite development. Based on this background, we have initiated synthetic research efforts to prepare GSLs (A-F). In this paper we report on the synthesis of GSLs (A-C; 1-3) this time. Disaccharide 1 contains the schisto-core sequence GalNAcb1→4Glcb1→Cer while trisaccharide 2 and tetrasaccharide 3 are elongated glycan sequences that contain a terminal schisto-core. Oligosaccharides 1-3 serve as molecular probes to explore glycosphingolipid-mediated interactions containing the schisto core in S. mansoni. The syntheses of di-and trisaccharide derivatives were conducted by stepwise synthesis of suitably protected monosaccharide-based glycosyl donors and acceptors. The tetrasaccharide derivative was conducted by block synthesis of a disaccharide acceptor and disaccharide donor.
Results and Discussion
The synthetic scheme for the synthesis of target compounds 1-3 are shown in Charts 1-3. Initially, the per-Oacylated 2-(trimethylsilyl)ethyl glycoside derivatives 8, 16 and 27 were prepared that serve as synthetic intermediates for the installation of the ceramide moiety. Glycosylation of 4 14) with 5 15) in the presence of trimethylsilyl trifluoromethanesulfonate (TMSOTf) 16) and 4 Å molecular sieves (MS 4 Å) in CH 2 Cl 2 gave the desired disaccharide (6) after purification in 97% yield. The anomeric proton of the GalNAc unit appeared as a doublet at d 4.30 (d, Jϭ8. 5 Hz) . Subsequently, the 2,2,2-trichloroethoxycarbonyl (Troc) group was converted to an acetamido moiety by reduction and Nacetylation with Zn-Ac 2 O-AcOH to afford 7 in 85% yield. Removal of benzyl group from 7 by catalytic hydrogenolysis over 10% Pd/C in MeOH and O-acetylation provided 8. Disaccharide derivative 6 was selected as precursor for the synthesis of trisaccharide 16. Two methods were studied for the selective deacetylation of 6 in the presence of benzoyl-and Troc-protecting groups. Initially, we attempted to selectively saponify the acetyl groups with p-toluenesulfonic acid 17) in CHCl 3 -MeOH to provide disaccharide 12 in 60% yield. However, the yield could be significantly improved by using guanidine/guanidinium nitrate reagent (G/GHNO 3 ) 18) that provided 12 in 89% yield. Benzylidenation 19) of disaccharide 12 produced acceptor 13, which was subjected to glycosylation with donor 14 20) 21) by deacetylation, benzylidenation, chloroacetylation, and reductive ring-opening of the benzylidene acetal as previously described.
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3) TMSOTfpromoted glycosylation of acceptor 20 with donor 21 22) was carried out in the presence of 4 Å MS in CH 2 Cl 2 and afforded the desired disaccharide 22 as the sole product in 86% yield. The b-glycosidic linkage in 22 was confirmed by 1 H-NMR spectroscopy. The anomeric proton of the galactose moiety appeared as a doublet with a homonuclear coupling constant of 7.9 Hz. Deblocking of the 3-O-chloroacetyl group in 22 was achieved with thiourea and the resulting alcohol 23 was converted into ester 24 by acetylation. Selective removal of the 2-(trimethylsilyl)ethyl group in 24 was achieved with trifluoroacetic acid in CH 2 Cl 2 , and treatment with CCl 3 CN in the presence of 1,8-diazabicyclo [5.4 .0]undec-7-ene (DBU) 23) to provide the corresponding a-trichloroacetimidate 25 in 74% yield. Tetrasaccharide derivative 26 was synthesized by coupling of donor 25 with disaccharide acceptor 13 in 83% yield. Deblocking of 26 was achieved using the same conditions as described for trisaccharide 16 produced the per-Oacylated tetrasaccharide derivative 27.
Next, for the selective removal of the 2-(trimethylsilyl)ethyl group, the fully acylated oligosaccharides 8, 16 and 27 were converted to the glycosyl imidate 9, 17 and 28. TMSOTf-promoted glycosylation of phytoceramide acceptor 10 24) with glycosyl donors 9, 17 and 28 afforded the desired b-glycosides 11 (57%), 18 (52%) and 29 (34%) yields, respectively. Finally, standard deacetylation and purification by column chromatography on Sephadex LH-20 furnished glycolipids 1-3.
Conclusion
In summary, a systematic and integrated approach for the synthesis of three glycosphingolipids 1-3 found in the parasite, Schistosoma mansoni has been accomplished. The synthetic strategy described may also find use for conjugation of the glycan portion of S. mansoni to other non-lipid-based carrier molecules. Biological testing for schistosomasis using GSLs 1-3 is currently in progress and results will be reported in detail elsewhere. It is expected that the prepared glycosphingolipids will find use in future studies designed to reveal the relationships between the structure and biological activity for specific antibody detection in patients with schistosomasis.
Experimental
General Methods Optical rotations were measured with a Jasco P-1020 digital polarimeter.
1 H-and 13 C-NMR spectra were recorded with a JMN A500 FT NMR spectrometer and a JEOL JNM-ECP600 with Me 4 Si as the internal standard for solutions in CDCl 3 . Matrix assisted laser desorption/ionization-time of flight (MALDI-TOF)-MS was recorded on an Applied Biosystems Voyager RP mass spectrometer. High-resolution mass spectra were recorded on a JEOL JMS-700 under FAB conditions. TLC was performed on Silica Gel 60 F254 (E. Merck) with detection by quenching of UV fluorescence and by charring with 10% H 2 SO 4 . Column chromatography was carried out on Silica Gel 60 (E. Merck). 21) were prepared as reported. Benzoylceramide 10 was prepared from phytosphingosine, which was purchased from Degussa (The Netherlands) by the conventional four-step procedure. (25.0 ml) was stirred under an atmosphere of argon for 18 h at room temperature, then cooled to Ϫ40°C. TMSOTf (62.3 ml, 0.34 mmol) was added, and the mixture was stirred for 3 h at Ϫ40°C, then neutralized with Et 3 N. The solids were filtrated off and washed with CHCl 3 . The combined filtrate and washings were successively washed with brine, dried (MgSO 4 ) and concentrated. The product was purified by silica gel column chromatography using 2 : 1 hexane-ethyl acetate as eluent to give 6 as an amorphous powder (3.10 g, 97% 
To a solution of 6 (1.0 g, 0.18 mol) in Ac 2 O (10 ml) and AcOH (5 ml) was added zinc powder (400 mg). The reaction mixture was stirred for 18 h at 40°C. After completion of the reaction, the mixture was filtered and extracted with CHCl 3 . The solution was washed with water, dried (MgSO 4 ), and concentrated. The filtrate was concentrated and purified by silica gel column chromatography using 3 : 1 toluene-acetone as the eluent to give 7 as syrup (737 mg, 85% in MeOH (4.0 ml) was hydrogenolysed under hydrogen in the presence of 10% Pd/C (400 mg) for 18 h at room temperature, then filtered and concentrated. The residue was acetylated with Ac 2 O (3.0 ml) in pyridine (4.5 ml). The reaction mixture was poured into ice H 2 O and extracted with CHCl 3 . The extract was washed sequentially with 5% HCl, aq NaHCO 3 , and brine, dried (MgSO 4 ), and concentrated. The residue was purified by silica gel column chromatography using 2 : 1 toluene-acetone as eluent to give 8 as syrup (305 mg, 95% 
To a solution of 8 (300 mg, 0.35 mmol) in CH 2 Cl 2 (3.0 ml), cooled to 0°C was added CF 3 CO 2 H (1.5 ml), and the mixture was stirred for 3 h at room temperature and concentrated. EtOAc and toluene (1 : 2) were added and evaporated to give the reducing sugar. To a solution of the residue in CH 2 Cl 2 (3.0 ml) cooled at 0°C were added DBU (53.1 ml, 0.35 mmol) and CCl 3 CN (0.36 ml, 3.49 mmol). The reaction mixture was stirred for 6 h at room temperature. After completion of the reaction, the mixture was concentrated. The residue was purified by silica gel column chromatography using 15 : 1 chloroform-methanol as eluent to give 9 as an amorphous powder (230 mg, 73% 2 Cl 2 (0.4 ml) was stirred under an atmosphere of argon for 18 h at room temperature, then cooled to 0°C. TMSOTf (97 ml, 35.4 mmol) was added, and the mixture was stirred for 3 h at room temperature, then neutralized with Et 3 N. The solids were filtrated off and washed with CHCl 3 . The combined filtrate and washings were successively washed with brine, dried (MgSO 4 ) and concentrated. The product was purified by flash silica gel column chromatography using 100 : 1 chloroform-methanol as eluent to give 11 as an amorphous powder (35.6 mg, 57% 1→1)-(2S,3S,4R)-2-palmitoylamidooctadecane-1,3,4-triol (1) To a solution of 10 (35.6 mg) in MeOH (1.5 ml) was added dioxane (1. 
2-(Trimethylsilyl)ethyl 4,6-O-Benzylidene-2-deoxy-2-(2,2,2-trichloroethoxycarbonylamino)-b b-D-galactopyranosyl-(1→4)-2,3-di-O-benzoyl-6-O-benzyl-b b-D-glucopyranoside (13)
To a solution of 12 (756 mg, 0.83 mmol) in CH 3 CN (10 ml) was added NaHSO 4 · SiO 2 (1.5 g) and benzaldehyde dimethyl acetal (BDA) (0.25 ml, 1.66 mmol, 2.0 eq). The reaction mixture was stirred for 2 h at room temperature, then neutralized with Et 3 N. The solids were filtrated off and the filtrated was concentrated. The product was purified by silica gel column chromatography using 10 : 1 toluene-acetone as eluent to give 13 as white solid (734 mg, 89%). [ 13 mmol) by the same method described for preparation of 6. The product was purified by silica chromatography using 3 : 2 hexane-ethyl acetate as eluent to give 15 as an amorphous powder (1.75 g, 85%) . [a] 2-Acetamido-O-3,4,6-tri-O-acetyl-2-deoxy-b b-Dgluctopyranosyl-(1→3)-2-acetamide-4,6-di-O-acetyl-2-deoxy-b b-D-galactopyranosyl-(1→4)-6-O-acetyl-2,3-di-O-benzoyl-b b -D-glucopyranoside  (16) To a solution of 15 (1.75 g, 0. 13 mmol) in Ac 2 O (10.0 ml) and AcOH (20.0 ml) was added zinc powder (3.0 g). The reaction mixture was stirred for 18 h at 45°C. After completion of the reaction, the mixture was filtered and the filtrate was diluted with CHCl 3 , washed with water, dried (MgSO 4 ) and concentrated to give the intermediate. To a solution of the residue in MeOH (10.0 ml) was added AcOH (5.0 ml) and hydrogenolysed under hydrogen in the presence of 10% Pd/C (500 mg) for 18 h at room temperature, then filtered and concentrated. The residue was acetylated with acetic anhydride (20.0 ml) in pyridine (30.0 ml). The reaction mixture was added toluene and concentrated. The residue was purified by silica gel column chromatography using 3 : 1 toluene-acetone as eluent to give 16 as syrup (855 mg, 62% -2-palmitoylamidooctadecane-1,3,4-triol (18) Compound 18 was prepared from 17 (110 mg, 93.0 mmol) and 10 (106 mg, 140 mmol) by the same method described for preparation of 11. The product was purified by silica chromatography using 60 : 1 chloroform-methanol as eluent to give 18 as syrup (85.8 mg, 52%). -D-galactopyranosyl-(1→4)-b b -D-glucopyranosyl-(1→1)-(2S,3S,4R)-2-palmitoylamidooctadecane-1,3 ,4-triol (2) Compound 2 was prepared from 18 (38.2 mg) by the same method described for preparation of 1. The product was purified by Sephadex LH-20 column chromatography in MeOH to give 2 as white solid 20.6 mg (86% 05 g, 72%) . To a solution of this compound (1.62 mg, 2.98 mmol) in CH 2 Cl 2 (30.0 ml) was added pyridine (6.0 ml) then cooled to 0°C. ClAcCl (0.48 ml, 5.97 mmol, 2.0 eq) was added, and the mixture was stirred for 5 h at room temperature. The mixture was diluted with CHCl 3 , washed with aq. 5% HCl, aq. NaHCO 3 and brine, dried (MgSO 4 ) and concentrated. The product was purified by silica gel column chromatography using 3 : 1 hexane-ethyl acetate as eluent to give 2-(trimethylsilyl)ethyl 4,6-O-benzylidene-3-O-chloroacetyl-2-deoxy-2-(2,2,2-trichloroethoxycarbonylamino)-b-D-glucopyranoside as an amorphous powder (1.39 g, 75%). To a solution of this compound (474 mg, 0.77 mmol) in THF (8.0 ml) was added 3 Å MS (500 mg) and NaBH 3 CN (386 mg, 6.16 mmol, 8.0 eq). The reaction mixture was stirred under an atmosphere of argon for 3 h at room temperature, then cooled to 0°C. HCl-Et 2 O (12.0 ml) was added. The addition was discontinued when the solution became acidic, and the mixture was stirred for 30 min at 0°C. The solids were filtrated off and washed with CHCl 3 . The combined filtrate and washings were successively washed with aq. NaHCO 3 and brine, dried (MgSO 4 ) and concentrated. The product was purified by silica gel column chromatography using 3 : 1 hexane-ethyl acetate as eluent to give 20 as syrup (410 mg, 86%). [ and concentrated. The product was purified by silica gel column chromatography using 3 : 2 hexane-ethyl acetate as eluent to give 23 as a white solid (624 mg, 85% The extract was washed sequentially with 5% HCl, aq. NaHCO 3 , and brine, dried (MgSO 4 ), and concentrated. The residue was purified by silica gel column chromatography using 2 : 1 hexane-ethyl acetate as eluent to give 24 as an amorphous powder (263 mg, 82% 2 Cl 2 (4.0 ml) was stirred under an atmosphere of argon for 2 h at room temperature, then cooled to Ϫ40°C. TMSOTf (3.2 ml, 0.02 mmol) was added, and the mixture was stirred for 2 h at Ϫ40°C, then neutralized with Et 3 N. The solids were filtrated off and washed with CHCl 3 . The combined filtrate and washings were successively washed with brine, dried (MgSO 4 ) and concentrated. The product was purified by silica gel column chromatography using 6 : 1 toluene-acetone as eluent to give 26 as an amorphous powder (262 mg, 83% 
2-Acetamido-3,4,6-tri-O-acetyl-2-deoxy-b b-D-gluctopyranosyl-(1→3)-2-acetamido-4,6-di-O-acetyl-2-deoxy-b b-D-galactopyranosyl-(1→4)-6-Oacetyl-2,3-di-O-benzoyl-1-O-a a-D-glucopyranosyl
-D-gluctopyranosyl-(1→3)-2- acetamido-4,6-di-O-acetyl-2-deoxy-b b-D-galactopyranosyl-(1→4)-6-O- acetyl-2,3-di-O-benzoyl-b b-D-glucopyranosyl-(1→1)-(2S,3S,4R)-3,4-di-O- benzoyl
